575 related articles for article (PubMed ID: 23095726)
21. Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study.
Han JM; Hwang JM; Kim JS; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):440-5. PubMed ID: 24370828
[TBL] [Abstract][Full Text] [Related]
22. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography.
Jaisankar D; Raman R; Sharma HR; Khandelwal N; Bhende M; Agrawal R; Sridharan S; Biswas J
Ocul Immunol Inflamm; 2019; 27(2):235-243. PubMed ID: 28700251
[TBL] [Abstract][Full Text] [Related]
23. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
24. Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography.
Invernizzi A; Mapelli C; Viola F; Cigada M; Cimino L; Ratiglia R; Staurenghi G; Gupta A
Retina; 2015 Mar; 35(3):525-31. PubMed ID: 25105317
[TBL] [Abstract][Full Text] [Related]
25. Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Tsuboi K; Nakai K; Iwahashi C; Gomi F; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):959-64. PubMed ID: 25663475
[TBL] [Abstract][Full Text] [Related]
26. [Pathophysiology of macular diseases--morphology and function].
Iida T
Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
[TBL] [Abstract][Full Text] [Related]
27. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.
Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820
[TBL] [Abstract][Full Text] [Related]
28. Morphologic choroidal and scleral changes at the macula in tilted disc syndrome with staphyloma using optical coherence tomography.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8763-8. PubMed ID: 21989725
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Three-Dimensional Choroidal Volume with Enhanced Depth Imaging Findings in Patients with Recurrent Vogt-Koyanagi-Harada Disease.
Silpa-Archa S; Ittharat W; Chotcomwongse P; Preble JM; Foster CS
Curr Eye Res; 2021 Jul; 46(7):1010-1017. PubMed ID: 33215546
[No Abstract] [Full Text] [Related]
30. Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and age-related macular degeneration.
Coscas F; Puche N; Coscas G; Srour M; Français C; Glacet-Bernard A; Querques G; Souied EH
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):64-9. PubMed ID: 24282233
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes.
Margolis R; Spaide RF
Am J Ophthalmol; 2009 May; 147(5):811-5. PubMed ID: 19232559
[TBL] [Abstract][Full Text] [Related]
32. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
[TBL] [Abstract][Full Text] [Related]
33. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
[TBL] [Abstract][Full Text] [Related]
34. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
35. Choroidal folds in Vogt-Koyanagi-Harada disease.
Wu W; Wen F; Huang S; Luo G; Wu D
Am J Ophthalmol; 2007 May; 143(5):900-901. PubMed ID: 17452188
[TBL] [Abstract][Full Text] [Related]
36. Choroidal thickness measurement in myopic eyes by enhanced depth optical coherence tomography.
Ho M; Liu DT; Chan VC; Lam DS
Ophthalmology; 2013 Sep; 120(9):1909-14. PubMed ID: 23683921
[TBL] [Abstract][Full Text] [Related]
37. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
Nazari H; Rao NA
Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
[TBL] [Abstract][Full Text] [Related]
38. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
[TBL] [Abstract][Full Text] [Related]
39. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Hirose S; Saito W; Yoshida K; Saito M; Dong Z; Namba K; Satoh H; Ohno S
Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
[TBL] [Abstract][Full Text] [Related]
40. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
Jap A; Chee SP
Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
